Do all kidney stones travel through the ureters?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Do All Kidney Stones Travel Through the Ureters?

No, not all kidney stones travel through the ureters—many remain asymptomatic in the kidney and never enter the ureter, while others that do enter the ureter may pass spontaneously, require intervention, or remain lodged.

Natural History of Kidney Stones

Stones That Remain in the Kidney

  • Many kidney stones remain asymptomatic within the renal collecting system and never enter the ureter 1
  • These stones may remain stable in size, grow over time, or eventually fragment without causing symptoms
  • The clinical literature focuses primarily on stones that have already entered the ureter, as these are the stones that typically cause renal colic and require medical attention 2

Stones That Enter the Ureter

When stones do migrate from the kidney into the ureter, their fate depends heavily on size and location:

Small Stones (≤5 mm):

  • 68% pass spontaneously in patients under observation (95% CI: 46% to 85%) 1
  • Stones ≤2 mm pass in an average of 8.2 days, with 95% passing within 31 days 3
  • Stones 2-4 mm pass in an average of 12.2 days, with 95% passing within 40 days 3
  • Only 4.8% of stones ≤2 mm require intervention 3

Medium Stones (5-10 mm):

  • 47% pass spontaneously (95% CI: 36% to 59%) 1
  • Stones 4-6 mm pass in an average of 22.1 days, with 95% passing within 39 days 3
  • Medical expulsive therapy with alpha-blockers increases passage rates to 77.3% compared to 54.4% with placebo 4

Large Stones (>10 mm):

  • Very low spontaneous passage rates
  • 50% of stones >5 mm require intervention 3
  • Urologic intervention is recommended as first-line treatment rather than observation 1, 5

Where Stones Lodge in the Ureter

Contrary to traditional teaching about three points of narrowing, stones actually lodge at two primary locations when patients present with renal colic:

  • 60.6% at the ureterovesical junction (UVJ) 2
  • 23.4% in the proximal ureter between the ureteropelvic junction and iliac vessels 2
  • 10.6% at the ureteropelvic junction (UPJ) 2
  • Only 1.1% where the ureter crosses the iliac vessels, despite this being described as a classic narrowing point 2, 6

Important finding: Proximal stones are significantly larger than distal stones (mean 6.1 mm vs 4.0 mm axial diameter), suggesting smaller stones migrate further before lodging 2

Clinical Implications

Observation Period Safety

  • Ureteral stones cause obstruction and distension that typically produces at least some discomfort 1
  • Complete unilateral ureteral obstruction beyond 6 weeks risks irreversible kidney injury 5
  • Maximum conservative management period is 4-6 weeks from initial presentation 5

When Intervention Is Required

Stones require surgical management when:

  • Size >10 mm (low spontaneous passage rates) 4
  • Infection/sepsis develops 5
  • Declining renal function occurs 5
  • Refractory pain despite medical management 5
  • No passage after 4-6 weeks of observation 5

Treatment Success Rates

When intervention is needed, ureteroscopy achieves excellent outcomes:

  • 94% stone-free rate for distal ureteral stones 4
  • 86% stone-free rate for mid-ureteral stones 4
  • 81% stone-free rate for proximal ureteral stones 4

Common Pitfalls to Avoid

  • Do not assume all kidney stones will cause symptoms—many remain in the kidney indefinitely without entering the ureter 1
  • Do not wait beyond 6 weeks for spontaneous passage due to risk of irreversible renal damage 5
  • Do not rely on the "three points of narrowing" teaching for predicting stone location—most stones lodge at the UVJ or proximal ureter 2, 6
  • Do not offer prolonged observation for stones >10 mm—these require intervention as first-line treatment 1, 5

References

Guideline

Asymptomatic Stone Passage Rates

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Tamsulosin for Kidney Stones

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Can a kidney stone move from the proximal ureter to the distal ureter?
What is the recommended emergency department disposition for a patient with a 5mm ureteral stone and impaired renal function?
Can a 5mm kidney stone pass on its own?
Can a 6mm kidney stone pass on its own without medical supervision?
What is the minimum size of a kidney stone that can get stuck in the ureter?
What is the recommended prophylaxis for Spontaneous Bacterial Peritonitis (SBP) in patients with cirrhosis and ascites?
What adjustments should be made to the medication regimen of an adult patient with recurrent severe Major Depressive Disorder (MDD), Obsessive-Compulsive Disorder (OCD), Generalized Anxiety Disorder (GAD), and Attention Deficit Hyperactivity Disorder (ADHD), currently taking sertraline (200mg), lamotrigine (100mg), guanfacine (Guanfacine) Extended Release (ER) (2mg) at bedtime, and clonazepam (1mg), who continues to experience OCD symptoms, anxiety, and hopelessness?
What is the best course of action for a female patient with a history of mental health issues, currently experiencing persistent symptoms of depression and anxiety, despite being on a medication regimen of Duloxetine (60mg), Lexapro (10mg) (Escitalopram), Remeron (15mg) (Mirtazapine), and Hydroxyzine (50mg) as needed, and presenting with feelings of laziness, emotional upset, and social anxiety?
What is a therapeutic interchange for a patient with Chronic Obstructive Pulmonary Disease (COPD) or asthma currently taking Trelegy (fluticasone furoate, umeclidinium, and vilanterol)?
What is the approach to a comprehensive neurological assessment for a patient with a history of neurological conditions, such as epilepsy (seizure disorder) or multiple sclerosis (MS), and current medications, including antiepileptic drugs (AEDs)?
What is the appropriate treatment for a patient with a pneumothorax, considering the size of the pneumothorax and the presence of symptoms such as chest pain or difficulty breathing, and taking into account potential underlying conditions like chronic obstructive pulmonary disease (COPD) or asthma?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.